GE HealthCare Technologies Inc., a spin-off from General Electric in 2023, operates globally with a diversified portfolio spanning advanced medical imaging, pharmaceutical diagnostics, and AI-powered healthcare solutions. Its four core segments—Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics—complement each other to support a strong competitive moat reinforced by integration, scale, and regulatory barriers. While the company maintains solid financial performance with robust net income and liquidity as of 2025, it faces complex regulatory challenges and competitive pressures inherent in healthcare technology markets. Ongoing investments in AI and cloud capabilities signal GE HealthCare’s strategic focus on innovation to drive clinical outcomes and customer loyalty across more than 160 countries.